RIL
Rothschild Investment LLC Portfolio holdings
AUM
$1.6B
1-Year Return
17.99%
This Quarter Return
+14.65%
1 Year Return
+17.99%
3 Year Return
+73.94%
5 Year Return
+135.61%
10 Year Return
+254.21%
AUM
$1.04B
AUM Growth
+$118M
(+13%)
Cap. Flow
-$10.4M
Cap. Flow
% of AUM
-1.01%
Top 10 Holdings %
Top 10 Hldgs %
20.79%
Holding
485
New
49
Increased
149
Reduced
167
Closed
28
Top Buys
| 1 |
Annaly Capital Management
NLY
|
+$6.53M |
| 2 |
Lockheed Martin
LMT
|
+$2.22M |
| 3 |
Aon
AON
|
+$2.2M |
| 4 |
H.B. Fuller
FUL
|
+$947K |
| 5 |
Intuitive Surgical
ISRG
|
+$912K |
Top Sells
| 1 |
AT&T
T
|
+$6.45M |
| 2 |
Cboe Global Markets
CBOE
|
+$5.69M |
| 3 |
AbbVie
ABBV
|
+$4.35M |
| 4 |
Ambarella
AMBA
|
+$2.8M |
| 5 |
Financial Select Sector SPDR Fund
XLF
|
+$1.97M |
Sector Composition
| 1 | Technology | 15.64% |
| 2 | Healthcare | 14.82% |
| 3 | Financials | 10.43% |
| 4 | Industrials | 8.64% |
| 5 | Consumer Discretionary | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ATVI
226
DELISTED
Activision Blizzard Inc.
ATVI
| $604K | 0.06% |
6,505
-2,192
| -25% | -$204K |
|
227
Takeda Pharmaceutical
TAK
$48.2B
| $592K | 0.06% |
32,548
-356
| -1% | -$6.48K |
|
228
DuPont de Nemours
DD
$32.6B
| $586K | 0.06% |
8,242
-481
| -6% | -$34.2K |
|
229
Marriott International Class A Common Stock
MAR
$72.8B
| $584K | 0.06% |
4,424
| – | – |
|
230
Darden Restaurants
DRI
$24.6B
| $578K | 0.06% |
4,850
+560
| +13% | +$66.7K |
|
231
Viatris
VTRS
$12.2B
| $572K | 0.06% |
+30,523
| New | +$572K |
|
232
Comcast
CMCSA
$126B
| $565K | 0.05% |
10,780
-200
| -2% | -$10.5K |
|
|
TVRD
233
Tvardi Therapeutics, Inc. Common Stock
TVRD
$278M
| $551K | 0.05% |
1,011
+100
| +11% | +$54.5K |
|
234
Air Products & Chemicals
APD
$64.3B
| $546K | 0.05% |
2,000
| – | – |
|
235
State Street
STT
$31.7B
| $546K | 0.05% |
7,500
| – | – |
|
236
US Bancorp
USB
$75.7B
| $529K | 0.05% |
11,357
-1,200
| -10% | -$55.9K |
|
237
SPDR Dow Jones Industrial Average ETF Trust
DIA
$39.9B
| $523K | 0.05% |
1,710
+68
| +4% | +$20.8K |
|
238
Apollo Global Management
APO
$76.9B
| $518K | 0.05% |
10,585
+500
| +5% | +$24.5K |
|
239
Ares Capital
ARCC
$15.9B
| $516K | 0.05% |
30,565
-13,000
| -30% | -$219K |
|
240
Hanesbrands
HBI
$2.28B
| $513K | 0.05% |
35,198
-750
| -2% | -$10.9K |
|
241
Dentsply Sirona
XRAY
$2.83B
| $509K | 0.05% |
9,725
-200
| -2% | -$10.5K |
|
|
VGR
242
DELISTED
Vector Group Ltd.
VGR
| $505K | 0.05% |
61,092
-1,272
| -2% | -$10.5K |
|
|
ABMD
243
DELISTED
Abiomed Inc
ABMD
| $503K | 0.05% |
1,550
| – | – |
|
244
Equinix
EQIX
$74.9B
| $502K | 0.05% |
703
| – | – |
|
245
Affiliated Managers Group
AMG
$6.57B
| $499K | 0.05% |
4,912
+211
| +4% | +$21.4K |
|
246
Arthur J. Gallagher & Co
AJG
$76.7B
| $495K | 0.05% |
+4,001
| New | +$495K |
|
247
WillScot Mobile Mini Holdings
WSC
$4.22B
| $491K | 0.05% |
21,225
-3,451
| -14% | -$79.8K |
|
248
Pacira BioSciences
PCRX
$1.2B
| $490K | 0.05% |
8,190
-808
| -9% | -$48.3K |
|
249
Strategy Inc Common Stock Class A
MSTR
$93.5B
| $486K | 0.05% |
+12,500
| New | +$486K |
|
250
Albemarle
ALB
$9.65B
| $483K | 0.05% |
3,272
| – | – |
|